InterCure Ltd.
NASDAQ: INCR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Alexander Rabinovich
- Employees
- 320
- Headquarters
- Herzliya, Israel
- IPO year
- 2019
- Market cap
- $57.2M
- Website
- https://www.intercure.co
Loading INCR…
Loading profile data…Frequently asked questions about INCR
What does InterCure Ltd. (INCR) do?
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabi...
Where does INCR trade?
InterCure Ltd. (INCR) trades on the NASDAQ Global Market.
What sector is INCR in?
InterCure Ltd. (INCR) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of InterCure Ltd.?
Alexander Rabinovich is the chief executive officer of InterCure Ltd. (INCR).
Where is InterCure Ltd. headquartered?
InterCure Ltd. is headquartered in Israel.
Does INCR pay a dividend?
InterCure Ltd. (INCR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INCR go public?
InterCure Ltd. (INCR) completed its initial public offering in 2019.